Island company to make experimental lung cancer drug
January 31st, 2007
A P.E.I. pharmaceutical company has signed a contract to make an experimental lung cancer drug for human clinical testing.BioVectra DCL will produce L-DOS47 for Helix BioPharma Corp. of Aurora, Ont. Helix specializes in developing cancer therapies